Ligand validation:6GIM

EZK: [4-[(3-chloranyl-4-imidazolidin-2-ylideneazaniumyl-phenyl)carbamoyl]phenyl]-imidazolidin-2-ylidene-azanium

EZK is a Ligand Of Interest in 6GIM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GIM_EZK_C_101	93%	50%	0.068	0.963	0.76	1.16	1	5	0	0	100%	0.5
6GIM_EZK_B_101	92%	45%	0.066	0.955	1.16	0.97	4	2	0	0	100%	1
6GIM_EZK_D_101	75%	48%	0.103	0.935	0.78	1.21	2	5	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.